Home | Business News | Browse by Publication | M | Medical Letter on the CDC & FDA

Researchers at Brigham and Women's Hospital publish new data on life sciences.

Publication: Medical Letter on the CDC & FDA
Publication Date: 20-SEP-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
"Fibromyalgia syndrome (FMS) is a condition classified by widespread chronic pain and is associated with fatigue, morning stiffness and disordered sleep Milnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) that was recently approved by FDA for the management of FMS. In clinical trials milnacipran has demonstrated efficacy in...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Medical Letter on the CDC & FDA
Mosquitoes Don't "Fall" Away as a Major Pest Problem When Summer Ends., September 20, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.